Literature DB >> 22082082

Montreal Cognitive Assessment (MoCA): normative study for the Portuguese population.

Sandra Freitas1, Mário R Simões, Lara Alves, Isabel Santana.   

Abstract

The Montreal Cognitive Assessment (MoCA) is a brief cognitive screening instrument with good psychometric features and an excellent sensitivity in the early detection of mild cognitive decline. The MoCA was applied to a community-based sample of cognitively healthy adults (n = 650), stratified according to sociodemographic variables (age, gender, educational level, geographic region, geographic localization, and residence area), with a distribution similar to that observed in the Portuguese population. The normative data were determined according to age and education as these were the sociodemographic variables that most significantly contributed to the prediction of the MoCA scores, explaining 49% of their variance.

Entities:  

Mesh:

Year:  2011        PMID: 22082082     DOI: 10.1080/13803395.2011.589374

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  74 in total

1.  A case of glioblastoma masquerading as an affective disorder.

Authors:  Albino J Oliveira-Maia; Joana Ruivo; J Bernardo Barahona-Corrêa
Journal:  Prim Care Companion CNS Disord       Date:  2014-12-25

2.  Comparison of alternate and original forms of the Montreal Cognitive Assessment (MoCA): an Italian normative study.

Authors:  Mattia Siciliano; Carlo Chiorri; Carla Passaniti; Valeria Sant'Elia; Luigi Trojano; Gabriella Santangelo
Journal:  Neurol Sci       Date:  2019-01-14       Impact factor: 3.307

3.  Montreal Cognitive Assessment (MoCA)-Italian version: regression based norms and equivalent scores.

Authors:  Silvia Conti; Stefano Bonazzi; Marcella Laiacona; Marco Masina; Mirco Vanelli Coralli
Journal:  Neurol Sci       Date:  2014-08-20       Impact factor: 3.307

4.  The impact of breast cancer treatments on sleep quality 1 year after cancer diagnosis.

Authors:  Filipa Fontes; Susana Pereira; Ana Rute Costa; Marta Gonçalves; Nuno Lunet
Journal:  Support Care Cancer       Date:  2017-06-16       Impact factor: 3.603

5.  Human predisposition to cognitive impairment and its relation with environmental exposure to potentially toxic elements.

Authors:  Marina M S Cabral Pinto; A Paula Marinho-Reis; Agostinho Almeida; Carlos M Ordens; Maria M V G Silva; Sandra Freitas; Mário R Simões; Paula I Moreira; Pedro A Dinis; M Luísa Diniz; Eduardo A Ferreira da Silva; M Teresa Condesso de Melo
Journal:  Environ Geochem Health       Date:  2017-03-09       Impact factor: 4.609

6.  Normative data for the Montreal Cognitive Assessment in an Italian population sample.

Authors:  Gabriella Santangelo; Mattia Siciliano; Roberto Pedone; Carmine Vitale; Fabrizia Falco; Rossella Bisogno; Pietro Siano; Paolo Barone; Dario Grossi; Franco Santangelo; Luigi Trojano
Journal:  Neurol Sci       Date:  2014-11-08       Impact factor: 3.307

7.  Cognitive complaints in Parkinson's disease patients: from subjective cognitive complaints to dementia and affective disorders.

Authors:  Raquel P Barbosa; Marcelo D Mendonça; André P Caetano; Tania M Lampreia; Rita Miguel; Paulo M Bugalho
Journal:  J Neural Transm (Vienna)       Date:  2019-07-05       Impact factor: 3.575

8.  Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study.

Authors:  Susana Pereira; Filipa Fontes; Teresa Sonin; Teresa Dias; Maria Fragoso; José M Castro-Lopes; Nuno Lunet
Journal:  Support Care Cancer       Date:  2015-09-18       Impact factor: 3.603

9.  Normative Data for the Montreal Cognitive Assessment in Middle-Aged and Elderly Quebec-French People.

Authors:  Eddy Larouche; Marie-Pier Tremblay; Olivier Potvin; Sophie Laforest; David Bergeron; Robert Laforce; Laura Monetta; Linda Boucher; Pascale Tremblay; Sylvie Belleville; Dominique Lorrain; Jean-François Gagnon; Nadia Gosselin; Christian-Alexandre Castellano; Stephen C Cunnane; Joël Macoir; Carol Hudon
Journal:  Arch Clin Neuropsychol       Date:  2016-11-22       Impact factor: 2.813

10.  Outcome measures for Parkinson's disease dementia: a systematic review.

Authors:  Samantha K Holden; Wallace E Jones; Keith A Baker; Isabel M Boersma; Benzi M Kluger
Journal:  Mov Disord Clin Pract       Date:  2015-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.